Roberto Bergamaschi

Serum and CSF levels of MCP-1 and IP-10 in multiple sclerosis patients with acute and stable disease and undergoing immunomodulatory therapies

Diego Franciotta, Gianvito Martino, Elisabetta Zardini et al. · Journal of Neuroimmunology · 2001 · 175 citations

Life Sciences, Immunology, Neurology +17

Clinical aspects of fatigue in multiple sclerosis.

Roberto Bergamaschi, A. Romani, Maurizio Versino et al. · PubMed · 1998 · 114 citations

Medicine, Neurology, Disability Management +13

Effect of Disease-Modifying Therapy on Disability in Relapsing-Remitting Multiple Sclerosis Over 15 Years

Tomáš Kalinčík, Ibrahima Diouf, Sifat Sharmin et al. · Neurology · 2020 · 98 citations · Full text

Education, Neurology, Disability Management +16

Risk of secondary progressive multiple sclerosis: A longitudinal study

Adam Fambiatos, Vilija Jokubaitis, Dana Horáková et al. · Multiple Sclerosis Journal · 2019 · 83 citations · Full text

Public Health, Chronic Disease Prevention, Disability Management +9

Natalizumab, Fingolimod, and Dimethyl Fumarate Use and Pregnancy-Related Relapse and Disability in Women With Multiple Sclerosis

Wei Zhen Yeh, Putu Ayu Widyastuti, Anneke van der Walt et al. · Neurology · 2021 · 81 citations

Medicine, Obstetrics, Maternal-fetal Medicine +12